Head and neck cancer
I am interested in identifying events that promote genomic instability in cancer as well as identifying genes that genome-destabilizing events deregulate to promote the tumor phenotype. We have inactivated specific genes in noncancerous human cells, resulting in the induction of genomic instability and transformation. By microarray analysis, we have identified several novel genes that appear to be essential for the neoplastic transformation and are studying their function and possible utility as therapeutic targets.
- 1988: MD, Case Western Reserve University, Cleveland
- 1993: MBA, Columbia University, New York
- 1988 - 1989: Intern, Cleveland Clinic
- 1992 - 1994: Research fellow, Columbia University, New York
- 1994 - 1996: Resident, medicine, Mount Sinai Medical Center, New York
- 1996 - 1999: Fellow, hematology and oncology, Memorial Sloan-Kettering Cancer Center, New York
- 1999 - 2004: Research fellow, Sloan-Kettering Institute
- 1999 - 2004: Fellow, medicine, Weill Medical College of Cornell University, New York
- 1996: American Board of Internal Medicine, Internal Medicine
- 1999: American Board of Internal Medicine, Oncology
Disclaimer: This listing may not include all articles associated with this physician and may include publications related to other physicians with a similar name.